Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 26.6x - 29.5x | 28.1x |
| Selected Fwd P/E Multiple | 22.1x - 24.5x | 23.3x |
| Fair Value | ﷼90.02 - ﷼99.50 | ﷼94.76 |
| Upside | 15.1% - 27.2% | 21.2% |
| Benchmarks | - | Full Ticker |
| Al Hammadi Holding Company | 400,700.0% | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 401,300.0% | SASE:4013 |
| Middle East Healthcare Company | 400,900.0% | SASE:4009 |
| National Medical Care Company | 400,500.0% | SASE:4005 |
| Dr. Soliman Abdel Kader Fakeeh Hospital Company | 401,700.0% | SASE:4017 |
| Mouwasat Medical Services Company | 400,200.0% | SASE:4002 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| 4007 | 4013 | 4009 | 4005 | 4017 | 4002 | |||
| SASE:4007 | SASE:4013 | SASE:4009 | SASE:4005 | SASE:4017 | SASE:4002 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 29.5% | 21.6% | 23.6% | 30.1% | -0.9% | 8.9% | ||
| 3Y CAGR | 50.8% | 18.9% | 154.0% | 29.8% | -4.9% | 3.8% | ||
| Latest Twelve Months | 21.9% | 10.1% | 3545.6% | 13.6% | 2.4% | 1.3% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 20.5% | 20.0% | 3.9% | 18.0% | 11.7% | 26.5% | ||
| Prior Fiscal Year | 25.8% | 21.5% | 0.6% | 22.3% | 12.0% | 24.3% | ||
| Latest Fiscal Year | 29.4% | 20.7% | 9.8% | 23.0% | 10.3% | 22.4% | ||
| Latest Twelve Months | 29.6% | 19.6% | 13.6% | 21.9% | 10.2% | 23.0% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 15.1x | 35.4x | 12.1x | 20.8x | 23.4x | 16.3x | ||
| Price / LTM Sales | 5.1x | 8.0x | 1.8x | 5.4x | 3.3x | 5.4x | ||
| LTM P/E Ratio | 17.3x | 40.7x | 13.4x | 24.5x | 32.6x | 23.4x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | 13.4x | 24.5x | 40.7x | |||||
| Historical LTM P/E Ratio | 25.9x | 30.3x | 37.3x | |||||
| Selected P/E Multiple | 26.6x | 28.1x | 29.5x | |||||
| (x) LTM Net Income | 671 | 671 | 671 | |||||
| (=) Equity Value | 17,888 | 18,829 | 19,771 | |||||
| (/) Shares Outstanding | 200.0 | 200.0 | 200.0 | |||||
| Implied Value Range | 89.44 | 94.15 | 98.85 | |||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 89.44 | 94.15 | 98.85 | 78.20 | ||||
| Upside / (Downside) | 14.4% | 20.4% | 26.4% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4007 | 4013 | 4009 | 4005 | 4017 | 4002 | |
| Value of Common Equity | 6,080 | 93,450 | 5,430 | 7,553 | 9,430 | 15,640 | |
| (/) Shares Outstanding | 160.0 | 350.0 | 92.0 | 44.7 | 230.0 | 200.0 | |
| Implied Stock Price | 38.00 | 267.00 | 59.00 | 169.00 | 41.00 | 78.20 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 38.00 | 267.00 | 59.00 | 169.00 | 41.00 | 78.20 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |